Opinion

Video

Patient Profile 1: A 70-Year-Old Man With PSMA-Positive mCRPC

Oliver Sartor, MD, discusses how a 70-year-old man with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) represents a typical candidate for PSMA-targeted imaging and potential radioligand therapy, considering factors such as disease progression, previous treatments, and overall health status in tailoring management strategies.

Related Videos
1 expert is featured in this series.
Medcast series
1 expert is featured in this series.
1 expert is featured in this series.
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.